Exclusivity Information
Cosacthen holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2030. Details of Cosacthen's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Dec 19, 2030 |
About Cosacthen
Cosacthen is a drug
owned by DECHRA, LTD.
Cosacthen uses
Cosyntropin as the active
ingredient.
Active Ingredient:
Cosacthen uses
Cosyntropin as the active ingredient.
Check out other Drugs and Companies using
Cosyntropin ingredient.